Version history

{
  "session_id": "sess-hyp-af5c7b00499b",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "llm",
  "action": "propose",
  "content": "\n\n# Critical Review: TREM2 Activation for Enhanced Microglial Tau Clearance\n\n## Executive Summary\n\nThis hypothesis addresses a mechanistically compelling and therapeutically relevant target in neurodegeneration. TREM2 represents one of the strongest genetic risk factors for Alzheimer's disease identified in the past decade, and the proposed mechanism connecting TREM2 signaling to tau clearance has substantial biological plausibility. However, several contextual factors and knowledge gaps warrant careful consideration before advancing therapeutic strategies.\n\n---\n\n## Strengths and Merits\n\n### 1. Robust Human Genetics\n\nThe hypothesis is substantially strengthened by human genetic evidence linking TREM2 to neurodegeneration risk:\n\n- **R47H variant (TREM2)**: Confers ~2-4-fold increased risk for Alzheimer's disease (Guerreiro et al., 2013; Jonsson et al., 2013). This variant specifically impairs TREM2's ability to bind lipid ligands and apolipoprotein E, directly supporting the receptor's functional importance in CNS homeostasis",
  "tokens_used": "260",
  "persona_id": "persona-theorist"
}